CARLSBAD, Calif., July 30, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Wednesday, August 7th at 11:30 a.m. Eastern Time to discuss its second quarter 2019 financial results and report on pipeline and business progress.

MONMOUTH JUNCTION, N.J., July 30, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader commercializing its 

LITTLE FALLS, N.J. and CHICAGO, July 30, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE:CMD) ("Cantel" or the "Company"), a global leader in instrument reprocessing and innovative infection prevention products and services, today announced that it has entered into a definitive agreement to acquire privately-held Hu-Friedy Mfg. Co. ("Hu-F

TORONTO, July 30, 2019 /PRNewswire/ -- Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB: ASPCF) today announced that it will be taking an expanded role in the commercialization of NATESTO® in the U.S. The company has entered into an amended and restated licensing agreement with Aytu BioScience, Inc. (NASDAQ: AYTU), which will, upon closing, move the

NEW YORK, July 30, 2019 /PRNewswire/ -- Welsh, Carson, Anderson & Stowe ("WCAS"), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that it has completed fundraising for WCAS XIII, L.P. ("WCAS XIII" or the "Fund"). The Fund, which was oversubscribed, closed at its hard cap of $4.3 bil

CALGARY, Alberta, July 30, 2019 /PRNewswire/ -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE: XRX; OTCQB: XRTXF; ANU1: FWB), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce that Dr. Allen Davidoff, CEO, will be p

LOS ANGELES, July 30, 2019 /PRNewswire/ -- WellSet, the first-of-its-kind technology booking platform connecting wellness seekers and trusted peer-reviewed practitioners, announced today that it has se

CHICAGO, July 30, 2019 /PRNewswire/ -- As the United States faces the continued challenges of a growing opioid epidemic, the women clinicians, executives and executive directors of Footprints to Recovery refuse to back down. With over 80 years of combined experience spanning substance abuse, eating disorders and mental health, these women

SAN DIEGO, July 30, 2019 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced that Daniel Vitt, Ph.D., Chief Executive Officer and P

INDIANAPOLIS, July 30, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced financial results for the second quarter of 2019.